The cytochrome P450 (CYP)4F2 gene is known to influence mean coumarin dose. The aim of the present study was to undertake a meta-analysis at the individual patients level to capture the possible effect of ethnicity, gene-gene interaction, or other drugs on the association and to verify if inclusion of CYP4F2*3 variant into dosing algorithms improves the prediction of mean coumarin dose. We asked the authors of our previous meta-analysis (30 articles) and of 38 new articles retrieved by a systematic review to send us individual patients' data. The final collection consists of 15,754 patients split into a derivation and validation cohort. The CYP4F2*3 polymorphism was consistently associated with an increase in mean coumarin dose (+9% (95% confidence interval (CI) 7-10%), with a higher effect in women, in patients taking acenocoumarol, and in white patients. The inclusion of the CYP4F2*3 in dosing algorithms slightly improved the prediction of stable coumarin dose. New pharmacogenetic equations potentially useful for clinical practice were derived.

Danese, E., Raimondi, S., Montagnana, M., Tagetti, A., Langaee, T., Borgiani, P., et al. (2019). Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105(6), 1477-1491-1491 [10.1002/cpt.1323].

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

Borgiani, Paola;Ciccacci, Cinzia;Sacchetti, Lucia;
2019-06-01

Abstract

The cytochrome P450 (CYP)4F2 gene is known to influence mean coumarin dose. The aim of the present study was to undertake a meta-analysis at the individual patients level to capture the possible effect of ethnicity, gene-gene interaction, or other drugs on the association and to verify if inclusion of CYP4F2*3 variant into dosing algorithms improves the prediction of mean coumarin dose. We asked the authors of our previous meta-analysis (30 articles) and of 38 new articles retrieved by a systematic review to send us individual patients' data. The final collection consists of 15,754 patients split into a derivation and validation cohort. The CYP4F2*3 polymorphism was consistently associated with an increase in mean coumarin dose (+9% (95% confidence interval (CI) 7-10%), with a higher effect in women, in patients taking acenocoumarol, and in white patients. The inclusion of the CYP4F2*3 in dosing algorithms slightly improved the prediction of stable coumarin dose. New pharmacogenetic equations potentially useful for clinical practice were derived.
giu-2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/03 - GENETICA MEDICA
English
Danese, E., Raimondi, S., Montagnana, M., Tagetti, A., Langaee, T., Borgiani, P., et al. (2019). Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105(6), 1477-1491-1491 [10.1002/cpt.1323].
Danese, E; Raimondi, S; Montagnana, M; Tagetti, A; Langaee, T; Borgiani, P; Ciccacci, C; Carcas, Aj; Borobia, Am; Tong, Hy; Dávila-Fajardo, C; Rodrigues Botton, M; Bourgeois, S; Deloukas, P; Caldwell, Md; Burmester, Jk; Berg, Rl; Cavallari, Lh; Drozda, K; Huang, M; Zhao, L; Cen, H; Gonzalez-Conejero, R; Roldan, V; Nakamura, Y; Mushiroda, T; Gong, Iy; Kim, Rb; Hirai, K; Itoh, K; Isaza, C; Beltrán, L; Jiménez-Varo, E; Cañadas-Garre, M; Giontella, A; Kringen, Mk; Haug, Kbf; Gwak, Hs; Lee, Ke; Minuz, P; Lee, Mtm; Lubitz, Sa; Scott, S; Mazzaccara, C; Sacchetti, L; Genç, E; Özer, M; Pathare, A; Krishnamoorthy, R; Paldi, A; Siguret, V; Loriot, M; Kutala, Vk; Suarez-Kurtz, G; Perini, J; Denny, Jc; Ramirez, Ah; Mittal, B; Rathore, Ss; Sagreiya, H; Altman, R; Shahin, Mha; Khalifa, Si; Limdi, Na; Rivers, C; Shendre, A; Dillon, C; Suriapranata, Im; Zhou, H; Tan, S; Tatarunas, V; Lesauskaite, V; Zhang, Y; Maitland-van der Zee, Ah; Verhoef, Ti; de Boer, A; Taljaard, M; Zambon, Cf; Pengo, V; Zhang, Je; Pirmohamed, M; Johnson, Ja; Fava, C
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
danese2018.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 2.13 MB
Formato Adobe PDF
2.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
danese2018.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 2.13 MB
Formato Adobe PDF
2.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/214484
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 21
social impact